Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Personal Disord. 2015 Apr;6(2):168–181. doi: 10.1037/per0000100

Rapid-Response Impulsivity: Definitions, Measurement Issues, and Clinical Implications

Kristen R Hamilton 1,*, Andrew K Littlefield 2, Noelle C Anastasio 3, Kathryn A Cunningham 3,4, Latham H Fink 3, Victoria C Wing 5, Charles W Mathias 6, Scott D Lane 7, Christian Schutz 8, Alan C Swann 7, CW Lejuez 1, Luke Clark 9, F Gerard Moeller 10, Marc N Potenza 11
PMCID: PMC4476624  NIHMSID: NIHMS659912  PMID: 25867840

Abstract

Impulsivity is a multi-faceted construct that is a core feature of multiple psychiatric conditions and personality disorders. However, progress in understanding and treating impulsivity in the context of these conditions is limited by a lack of precision and consistency in its definition and assessment. Rapid-response-impulsivity (RRI) represents a tendency toward immediate action that occurs with diminished forethought and is out of context with the present demands of the environment. Experts from the International Society for Research on Impulsivity (InSRI) met to discuss and evaluate RRI-measures in terms of reliability, sensitivity, and validity with the goal of helping researchers and clinicians make informed decisions about the use and interpretation of findings from RRI-measures. Their recommendations are described in this manuscript. Commonly-used clinical and preclinical RRI-tasks are described, and considerations are provided to guide task selection. Tasks measuring two conceptually and neurobiologically distinct types of RRI, “refraining from action initiation” (RAI) and “stopping an ongoing action” (SOA) are described. RAI and SOA-tasks capture distinct aspects of RRI that may relate to distinct clinical outcomes. The InSRI group recommends that: 1) selection of RRI-measures should be informed by careful consideration of the strengths, limitations, and practical considerations of the available measures; 2) researchers use both RAI and SOA tasks in RRI studies to allow for direct comparison of RRI types and examination of their associations with clinically relevant measures; and, 3) similar considerations should be made for human and non-human studies in an effort to harmonize and integrate pre-clinical and clinical research.

Keywords: impulsivity, response, attention, behavioral control, personality, assessment


Impulsive people have tendencies to act rapidly with diminished consideration of future consequences, often to their detriment. Impulsivity has been associated with a range of psychiatric conditions and represents a hallmark feature of multiple personality disorders (Swann, et al., 2002), with a focus on Cluster B personality disorders (PDs). Impulsivity has been associated with problem behaviors including substance use (de Wit, 2009; Lejuez, et al., 2010), problem gambling (Grant, et al., 2010; Lawrence, et al., 2009), aggression against others (Mouilso, et al., 2013), deliberate self-harm (Di Pierro, et al., 2012), and suicidality (Swann, et al., 2005).

As a construct, impulsivity can be measured either as a relatively stable characteristic using self-report questionnaires (Hamilton, et al., 2012; Littlefield, et al., 2010), or as a characteristic sensitive to contexts or states, which may be assessed by behavioral tasks and/or self-report assessments (Fillmore & Weafer, 2013). Different forms of impulsivity have been proposed, and factor analyses indicate the presence of two or more types of impulsivity (Meda, et al., 2009; Reynolds, et al., 2006). The number and types of impulsivity factors (or impulsivity-related factors) has been discussed and debated (Gullo, et al., 2014). For example, a recent review identified and described based on theoretical, behavioral and biological findings four domains of impulsivity relating to response, choice, reflection and decision-making (Fineberg, et al., 2014). Other studies have used factor analysis to identify separable constructs related to impulsivity, with up to five domains or factors identified depending on the study (Meda, et al., 2009; Reynolds, et al., 2006). There has been discussion regarding the boundaries of impulsivity, with some researchers calling for careful consideration of the number and types of domains contributing to impulsivity with a harkening for parsimony (Gullo, et al., 2014). Although multiple impulsivity-related domains have been identified, the constructs link back to definitions of impulsivity based on tendencies relating to acting rapidly and/or with diminished forethought or consideration of negative consequences to oneself or others (Fineberg, et al., 2014; Moeller, et al., 2001). Two types of impulsivity identified in multiple studies are delayed reward or “choice” impulsivity and rapid-response impulsivity (RRI) (Winstanley, et al., 2004a). Choice impulsivity is characterized by a diminished ability or willingness to tolerate delays. RRI reflects a tendency toward immediate action that is out of context with the present demands of the environment, and which occurs with diminished forethought; RRI also has been described as a diminished ability to inhibit prepotent responses (Moeller, et al., 2001).

Choice impulsivity and RRI are distinct constructs that, although they link back to the core theoretical definitions of impulsivity, they correlate weakly or not at all (Broos, et al., 2012; Lane, et al., 2003; Reynolds, et al., 2006), perhaps reflecting their differences in underlying neurobiology (van Gaalen, et al., 2006a; van Gaalen, et al., 2006b; Winstanley, et al., 2004b). Each type of impulsivity may contribute uniquely to specific phases of psychiatric disorders such as addictions (de Wit, 2009). However, conflation of types of impulsivity has led to inconsistencies across research domains and disciplines, slowing scientific progress (Cyders & Coskunpinar, 2011; Smith, et al., 2007).

Standardized RRI assessments are needed to inform research and clinical practice and to promote public health. Assessment of participants from the general population is required to examine the normative distribution of RRI, to study its association with risky behaviors, and to provide comparison data for groups diagnosed with specific disorders. Developmental changes in RRI throughout the lifespan (during childhood, adolescence, adulthood, and senium) also need to be examined. Within psychiatric samples, determination of associations with symptom severity, prognosis and treatment outcome is critical. Measures of RRI can be used to assess changes over time resulting from pharmacological and behavioral manipulations and changes in disorder states, e.g., incremental fluctuations in functioning over time in personality disorders to more discrete episode changes in mood disorders.

In order to address the existing situation, the International Society for Research on Impulsivity (InSRI) convened at the 2012 annual meeting to discuss the definition and assessment of RRI across species and in special populations (e.g., developmentally and in groups with psychiatric illness). RRI measures were considered in terms of reliability, sensitivity, and validity (See Table 1) with the goal of helping researchers and clinicians make informed decisions about the use and interpretation of findings from RRI measures. Differences in types of RRI were considered. Specifically, RRI measurement and theory identifies two basic types of conceptually and neurobiologically distinct inhibitory errors: (1) failure to refrain from action initiation (RAI; such as a No-Go response commission error on a Go/No Go task - GNG) vs. (2) failure to stop an ongoing or prepotent action (SOA; such as a stop error on a Stop-Signal Task - SST) (Rubia, et al., 2001; Swick, et al., 2011).

Table 1.

Human Lab Task Type of RRI Internal Validity External Validity Construct Validity Discriminant
Validity
Reliability Primary Outcome
Measures
Translational non-
human analog
Availability? Overall Strengths Overall
Weaknesses
InSRI
recommendation
GNG RAI Modest: (owing to many diff procedural variations) Strong Strong Modest: (may be correlated with other domains, eg., short term memory Modest: (generally stable but some versions my be subject to practice effects) False Alarms; d’ Direct:
Rat Go- No/Go
Monkey Go/No-Go
Public domain; Many versions Widely used; Est links to neurobiology and clinical outcomes; OK for repeated measures; Sensitive to manipulations (drug) Many diff procedural variants and measurement techniques; Potential influence by attentional factors? YES
CPT RAI Strong Strong Modest Modest (may be correlated with other domains such as attention) Good (generally stable and limited practice effects) Commission Errors/False Alarms/Catch Trials; d’ 5-CSRTT Public and private domain; a limited number of widely used versions. Widely used; Est links with clinical outcomes; OK for repeated measures; Sensitivity to manipulations; has been used in adolescents; norms available for Connors High attentional load; IMT variants may be influenced by working memory; few commission error trials makes less sensitive. YES
SST SOA Strong Strong Strong Strong Strong Stop Signal Reaction time (SSRT) Yes, has rodent and non- human primate analogs Many versions; most versions are in the public domain Widely used; Est links to neurobiology and clinical outcomes; OK for repeated measures; Sensitive to manipulations; variations used in children motivational considerations, Problems with data distribution, task is lengthy YES
Anti- Sac- cade RAI Modest Modest Modest Poor Strong Reaction time; failure to anti- saccade Yes, has non- human primate analogs Public domain Sensitive to manipulations (drug); can be administered throughout lifespan; less susceptible to motivational effects Costly; lack of standardization; susceptibility to confounds (e.g., differences in vision) YES

GNG = Go/No Go

CPT = Continuous Performance Test

SST = Stop Signal Task

RAI = Refraining from Action Initiation

SOA = Stopping and Ongoing Action

5-CSRTT = Five Choice Serial Reaction Time Task

RRI Neurocircuitry

Neuroimaging studies are valuable for identifying areas of activation implicated in RRI, and lesion studies (as well as studies involving temporary activation/inactivation of neural regions) provide critical confirmatory evidence of neuroimaging results (See Bari and Robbins, 2013, for a review). Response inhibition requires the activation of a complex circuit that includes the inferior frontal cortex and pre-SMA (pre-supplementary motor area) as major components (Bari & Robbins, 2013; Isoda & Hikosaka, 2007). Additional regions important for response inhibition that have been identified in fMRI and lesion studies include the SMA (Mostofsky, et al., 2003; Simmonds, et al., 2008), pre-motor cortex (Picton, et al., 2007; Watanabe, et al., 2002), parietal cortex (Menon, et al., 2001; Rubia, et al., 2001), ventrolateral prefrontal cortex (PFC) and insula (Bari & Robbins, 2013; Boehler, et al., 2010; Swick, et al., 2008). Lesion studies with rodents implicate the dorsomedial prefrontal cortex in RRI on the SST (Bari, et al., 2011) and five-choice serial reaction time task (5-CSRTT) (Muir, 1996; Paine, et al., 2011).

While there is some overlap in the neural regions activated during performance on the SST and GNG tasks, there also are regions of activation that are specific to each task (Fineberg, et al., 2014; Swick, et al., 2011). The neural correlates of RRI have been examined in meta-analyses (Buchsbaum, et al., 2005; Simmonds, et al., 2008), with some of these studies having examined SST performance together with GNG performance. The findings of these neuroimaging studies suggest that RRI is associated with a large-scale distributed system of bilateral cortical and subcortical regions, with right hemisphere dominance (Swick, et al., 2011).

It has been proposed that if distinct patterns of neural activation on the SST and GNG tasks exist, then it follows that the two tasks engage different cognitive processes (Lenartowicz, et al., 2010). In a meta-analysis in which SST-related activation was compared with GNG-related activation, key differences in the activation associated with each task were revealed (Swick, et al., 2011), supporting a conceptual distinction between RAI and SOA. In the GNG, right-lateralized clusters were activated to a greater extent in the middle and superior frontal gyri, the inferior parietal lobule, and the precuneus when compared with the SST. By contrast, two foci were activated to a greater extent in the SST than in the GNG: the thalamus and the left insula (Swick, et al., 2011).

While there were important differences in the neural correlates of GNG and SST performance in the meta-analysis examining the two tasks, there also were two primary areas of overlap: bilateral anterior insular regions and the SMA/pre-SMA ((Swick, et al., 2011). These regions have been characterized as part of a “salience network” that is activated by personally relevant stimuli (Seeley, et al., 2007). Hypotheses regarding insular involvement have been proposed that in addition to interoceptive awareness (Craig, 2009; Swick, et al., 2011) include responding to salient events and initiating cognitive control (Menon & Uddin, 2010), capturing focal attention and maintaining task set (Nelson, et al., 2010), and coordinating appropriate responses to internal and external events (Medford & Critchley, 2010). Based on their results, Swick and colleagues suggest that the insula is important for maintenance of task rules and readiness, rather than response inhibition per se. The overlapping activation observed in the SMA/pre-SMA during GNG and SST performance is consistent with previous suggestions that these regions are a critical part of the circuit that executes response inhibition (Chao, et al., 2009; Duann, et al., 2009; Mostofsky & Simmonds, 2008). The combination of overlapping and distinct areas of activation during GNG and SST performance provides support for different subtypes of RRI.

A description of the proceedings of and recommendations from the meeting follows. SOA and RAI tasks used to assess RRI in research with animal models and human participants are described, and the premises, characteristics, strengths and limitations of each task are considered (See Table 1).

Measurements of RRI in Animal Models

Preclinical measures of RRI are highly translational in that the tasks are employed across species (human, non-human primate, and rodent) with only minor alterations in design (Eagle, et al., 2008; Robbins, 2002; Winstanley, 2011). Thus, these tasks facilitate the investigation across species of the neurobiological underpinnings of behaviors and disorders characterized by RRI. Multiple tasks have been developed to assess RRI in animal models.

Go/No-Go Task (GNG)

The animal version of the GNG task requires the subject to learn to discriminate between two visual (or auditory) signals, one requiring a ‘go’ response and the other requiring that the response be withheld, a ‘no-go’ response, similar to the human versions of this task (Harrison, et al., 1999; Hogg & Evans, 1975). Trials are presented in random order, with stimuli ranging from presentation of a constant light and/or flashing light to variations in the light frequency (Harrison, et al., 1999). Stimulus dynamics may affect task acquisition and performance, complicating interpretation of results. Accordingly, careful consideration of the type of visual stimulus is warranted (Harrison, et al., 1999; Jakubowska & Gray, 1982). The proportion of ‘go’ to ‘no-go’ trials is essential, and symmetrical reinforcement of the ‘no-go’ trials is necessary to ensure that animals do not adopt a ‘go’ response bias (Harrison, et al., 1999; Perry & Carroll, 2008). The primary measure of RRI in this task is the number of inappropriate responses on ‘no-go’ trials (errors of commission, or false alarms). Additional measures include accuracy of responding, latency to respond correctly, and latency to retrieve the reinforcer.

The GNG task is highly translational. However, the GNG task has a decision-making element that can confound interpretation of RRI manipulations (Harrison, et al., 1999; Schachar, et al., 2007). While promising, the translational utility of the GNG task following neurochemical or pharmacological manipulations on action restraint (false alarms) is difficult to assess as insufficient work in this regard has been performed preclinically (Winstanley, 2011). Nonetheless, the GNG task in animals has proven useful in the dissection of the complex neurocircuitry underlying RAI (Eagle, et al., 2008).

Choice Serial Reaction Time (CSRT) Task

The CSRT tasks of attention and impulsive action are most closely modeled after the human Continuous Performance Task (CPT). These tasks include the widely employed five-choice serial reaction time (5-CSRT) task (Carli, et al., 1983; Hamilton, et al., 2014), as well as the one-choice (1-CSRT or ‘fixed-choice’) and two-choice (2-CSRT) variants (Anastasio, et al., 2011; Anastasio, et al., 2013; Cunningham, et al., 2013; Dalley, et al., 2002; Dillon, et al., 2009; Winstanley, et al., 2004a; Winstanley, et al., 2004b). These operant tasks entail a series of trials in which animals respond to a visual stimulus for delivery of a reinforcer. After completion of a trial, the animal must inhibit the acquired pre-potent response during an inter-trial interval (ITI); a response during the ITI, termed a premature response, is not reinforced and bears the further negative consequence of increased delay until the next trial. The principal measure of RRI is the premature response, which reflects a failure of RAI. Additional data include accuracy, omissions, and latency to collect the reinforcer, all of which can be used to delineate RRI from attentional and motivational processes.

Premature responses typically follow a normal distribution across populations and remain reliably stable over time (Dalley, et al., 2007). The CSRT tasks demonstrate excellent sensitivity to experimental manipulation with genetic, pharmacological, and neuroanatomical approaches, as well as to alterations of task parameters (Pattij & Vanderschuren, 2008; Robbins, 2002). Baseline premature response rates are low for typical employment of the 5-CSRT task relative to the 1- or 2-CSRT task variants; however, modification to a lengthened or variable ITI substantially increases premature responding (Carli, et al., 1983; Cole & Robbins, 1989; Dalley, et al., 2002). The high sensitivity of premature responding to ITI manipulations suggests a strong association between interval timing and this measure of RRI. Although it may appear that the involvement of interval timing may challenge construct validity of the CSRT tasks, clinical and preclinical studies have demonstrated a close, if not fundamental, relationship between interval timing and impulsivity (Rubia, et al., 2009).

The 1- and 2-CSRT tasks are less commonly employed but offer distinct advantages when assessing RRI. Decreased visual and attentional demands in these tasks may improve discriminant validity by reducing potential influence of these variables on task performance (Anastasio, et al., 2011; Anastasio, et al., 2013; Cunningham, et al., 2013; Dalley, et al., 2002; Winstanley, et al., 2004a). The elevated baseline premature responding in the 1- and 2-CSRT variants make these tasks amenable to experimental manipulations that reduce RRI, whereas a floor effect can hinder interpretation of such experiments in the 5-CSRT task. However, the neural mechanisms underlying premature responses in the 1-, 2- and 5-CSRT tasks may not be identical; each variant may rely more heavily on particular neural circuits or neurotransmitters, differentially yielding certain neural correlates of RRI. These possibilities require further experimental confirmation.

Stop Signal Task (SST)

The SST is similar to the GNG task except that the ‘stop’ signal is presented after the ‘go’ signal, thereby emphasizing the cancellation of a probable or ongoing motor response (Logan, et al., 1984; Verbruggen & Logan, 2009). Performance on the SST has been described using a ‘horse-race’ model, in which the stopping process and the reaction process (to the initial stimulus) compete for the first finishing time (Logan & Cowan, 1984). Following from this model, a response is inhibited when the stopping process finishes before the reaction process. In rodent models, animals are trained to respond (lever press) rapidly and accurately to first one then a second target following the ‘go’ signal; the time to execute this sequence is the mean reaction time (mRT). On a subset of trials, the ‘stop’ signal (e.g., auditory tone) is presented and the animal must cancel its prepotent response to obtain a reinforcer. Stop trials account for 20% of the trials in a test session and are randomly signaled after the rat responds on the first lever, but before the rat responds on the second lever. The delay to the stop signal varies across trials; prolonging the delay between the ‘go’ and ‘stop’ signals (i.e., presenting the ‘stop’ signal closer to the mRT) increases the difficulty to inhibit the response (i.e., increases stop errors). The primary measure of the SST is the stop-signal reaction time (SSRT), which is inferred from a subject’s mRT and inhibition of responding at different stop signal delays (Logan, et al., 1984).

The SST effectively measures SOA in both preclinical and clinical environments, a facet of RRI that is neuroanatomically and pharmacologically distinct from RAI (Eagle, et al., 2008; Eagle & Baunez, 2010; Eagle, et al., 2009; Rubia, et al., 2001; Winstanley, 2011). Further, inherent levels of premature responding in the 5-CSRT do not correlate to individual SSRTs (Robinson, et al., 2009), supporting the hypothesis that these tasks are elucidating independent measures of the RRI construct. One limitation of the SRT task is the critical requirement that animals respond to the ‘go’ signal as quickly as possible and cancel responding on all trials in which the ‘stop’ signal is delivered to accurately estimate the SSRT; failure to do so can result in the exclusion of subjects from final statistical analyses. The SST is highly amenable to experimental manipulations and exhibits very high cross-species comparability (Aron, 2003; Wiskerke, et al., 2011); however, its pharmacological predictive validity is dependent on the class of drugs under investigation (Eagle, et al., 2008; Winstanley, 2011).

Measurements of RRI in Humans

In addition to its harmful impact on behavior in normative populations, RRI is a principal component of a wide range of psychiatric conditions (Lipszyc & Schachar, 2010; Moeller, et al., 2001; Wright, et al., 2014). As in preclinical RRI measurement, clinical measurement of RRI typically involves either RAI or SOA.

Go/No Go (GNG)

The GNG task was designed to assess ability to inhibit inappropriate responses, and was originally adapted from a rodent measure (Iversen & Mishkin, 1970). The GNG instructions ask participants to make motor responses as rapidly as possible to visual presentations of stimuli designated as “Go,” and to withhold motor responses to stimuli with a “No Go” designation. “Go” events are typically more frequent than “no-go” events, in order to establish the “Go” response as dominant. (By contrast, the establishment of a dominant response is avoided in preclinical models, a procedural difference that should be considered when comparing clinical and preclinical GNG research). Errors of omission (withholding a response when a “Go” stimulus is presented) and errors of commission/false alarms (responding to a “No Go” stimulus) are recorded during the task, with the latter indexing RRI. The basic task can be modified in various ways. In reinforced versions of the GNG, participants are rewarded for correct responses and/or penalized for incorrect responses (Avila, 2001; Crockett, et al., 2009; Newman, et al., 1997). Affective versions of the GNG (e.g., Cambridge Neuropsychological Test Automated Battery; CANTAB) (Fray, et al., 1996) allow comparison of inhibitory control to emotional distractors of different valences (positive versus negative) (Murphy, et al., 1999).

Construct validity, or the degree to which an instrument measures the intended underlying construct, is evaluated by examining factors including the instrument’s content validity, internal structure, and relations to other variables (Cook & Beckman, 2006). By precisely assessing RRI, or the ability/willingness to withhold responses, the GNG demonstrates strong content validity (Moeller, et al., 2001). The GNG has a strong internal structure, which can be evaluated by examining the instrument’s reliability and factor structure (Cook & Beckman, 2006). With an r of 0.65, the GNG has a moderate to high level of test-retest reliability when participants were tested with a mean intersession interval of 8.6 days (Weafer, et al., 2013). The measure also has a strong factor structure, as it was part of a factor labeled “impulsive disinhibition” in a principal components analysis (Reynolds, et al., 2006). The relations of the GNG to other variables, which are evidenced by discriminant validity and concurrent validity, also provide support for the strong construct validity of the GNG. The discriminant validity of the GNG is evidenced by its exclusive assessment of RRI relative to choice impulsivity and behavioral risk-taking (Reynolds, et al., 2006). The GNG also has strong concurrent validity, correlating with other RRI measures such as the SST (Reynolds, 2006). Taken together, these sources of validity evidence support the construct validity of the GNG.

Additionally, the GNG is sensitive to manipulations such as drug administration (Sofuoglu, et al., 2012) and associates with clinical outcomes such as smoking cessation (Berkman, et al., 2011). The neural substrates of the GNG have been characterized in fMRI studies (Simmonds, et al., 2008). Additional strengths of the GNG include its high degree of translatability to preclinical models and its widespread use. From a practical perspective, GNG assessment is relatively brief and does not require extensive training. However, the different parameters of the many GNG variants may limit its internal validity, as multiple task variants may introduce confounding variables (Bodnar, et al., 2007). Furthermore, attention, vigilance, and working memory also may affect GNG performance, thereby increasing the complexity of data interpretation. The GNG has been used to examine response impulsivity in a wide range of psychiatric conditions, including attention-deficit hyperactivity disorder (ADHD), bipolar disorder, depression, and schizophrenia (Wright, et al., 2014). In a meta-analysis of psychiatric research, the mean effect size for higher response impulsivity on the GNG was 0.56 in bipolar disorder, 0.48 in ADHD, 0.29 in schizophrenia, and 0.32 in addiction (Wright, et al., 2014). In some research, participants with major depressive disorder had higher levels of response impulsivity on the GNG than did healthy control participants (Kaiser, et al., 2003; Katz, et al., 2010).

Even in fMRI studies in which there were no differences in GNG performance, there were differences in the patterns of neural activation associated with RRI in some psychiatric conditions. For example, in a study in which participants had similar GNG performance, patients with remitted major depression disorder (MDD) had hypoactivity in the right dorsomedial PFC (dmPFC) and right anterior cingulate cortex (rACC) during response inhibition when compared with healthy control participants (Nixon, et al., 2013). In a study of adolescents, there were no group differences in GNG performance among depressed adolescents who had attempted suicide, depressed adolescents who had not attempted suicide, and healthy control participants (Pan, et al., 2011). However, depressed adolescents who had not attempted suicide had greater activation during response inhibition in the right anterior cingulate cortex than depressed adolescents who had attempted suicide. Individuals with obsessive-compulsive disorder (OCD) displayed hypoactivity in fronto-striatal-thalamic networks during response inhibition when compared with healthy control participants (Page, et al., 2009; Roth, et al., 2007).

Findings from some neuroimaging studies suggest that greater activation in patient groups in areas associated with cognitive control may contribute to their ability to achieve the same level of response inhibition as healthy controls. For example, in a study in which patients with major depressive disorder had similar levels of response inhibition to healthy controls, the patients had greater activation in frontal, limbic, and temporal regions during response inhibition than healthy controls (Langenecker, et al., 2007). Furthermore, greater activation in many of these regions was predictive of treatment response in the MDD patients. In a study of cocaine-dependent participants with clean urine screens, increased activation to no-go cues in the bilateral postcentral gyri was prospectively associated with having used cocaine at an assessment that took place one week later (Prisciandaro, et al., 2013). Therefore, patterns of neural activation during response inhibition on the GNG may have value for characterizing different diagnostic groups and predicting behavioral outcomes.

Continuous Performance Test (CPT)

The CPT is a GNG with unique attributes. In the CPT, participants are instructed to respond to target stimuli and to inhibit responses to incorrect stimuli that are similar to the target. Responses to incorrect stimuli, or commission errors, index RRI. Although there are many versions of the CPT, all involve the maintenance of focus throughout the duration of a repetitive task to respond to targets or inhibit responses. Therefore, in addition to measuring RRI as indexed by errors of commission, the CPT also measures sustained and selective attention (indexed by errors of omission).

The content validity of the CPT is strong, as the task measures ability/willingness to inhibit responses (Moeller, et al., 2001). The CPT has high test-retest reliability with an r of .73 when the mean time between assessments was 8.6 days (Weafer, et al., 2013). In addition, the convergent validity of the CPT is high, as CPT performance is correlated with GNG performance (Weafer, et al., 2013). However, while high levels of content validity, reliability, and convergent validity support the construct validity of the CPT, reduced discriminant validity slightly diminishes the construct validity of the measure. The discriminant validity of the CPT is limited, as the task has commonly been used to measure attention (Harmell, et al., 2014; Posada, et al., 2012), vigilance (Bubnik, et al., 2014), and working memory (Bartes-Serrallonga, et al., 2014); impairments in these domains may impact task performance and reduce the number of trials that probe RRI via commission errors. Therefore, it is reasonable to conclude that although there is evidence to support the construct validity of the CPT, the evidence is not as strong as the evidence for the GNG task’s construct validity.

Strengths of the CPT include high external validity (Dougherty, et al., 2003; Schepis, et al., 2011; Strakowski, et al., 2010) and utility in adolescents (Schepis, et al., 2011). The Connors CPT-II, in particular, is widely used clinically and has a set of well-validated norms that facilitate comparisons across studies. However, different CPTs vary in task difficulty and response characteristics, and these differences warrant consideration in RRI studies. The CPT can be used during neuroimaging to provide information about the neural substrates underlying task performance (Moeller, et al., 2005; Ogg, et al., 2008; Sepede, et al., 2010), although the neural features associated with CPT performance have been studied less extensively than those associated with performance of the GNG and SST.

The CPT has been widely used in clinical samples. In the previously discussed meta-analysis of psychiatric research (Wright, et al., 2014), CPT effect sizes were comparable to effect sizes calculated from GNG research. The effect size for elevated scores on the CPT was 0.48 in bipolar disorder, 0.45 in ADHD, 0.37 in schizophrenia, and 0.30 in addiction (Wright, et al., 2014).

The CPT has been used to evaluate the effects of a pharmacological treatment on prefrontal activity in children with ADHD (Araki, et al., 2014). In an age-matched control group, children had increased oxygenated hemoglobin (oxy-Hb) concentration in the bilateral dorsolateral PFC (dlPFC). Children with ADHD, by contrast, did not have an increase in oxy-Hb concentration in the dlPFC during CPT performance; instead they had a decrease in oxy-Hb concentration in the ventrolateral prefrontal cortex (vlPFC). When the ADHD children were re-evaluated during CPT performance after six months of atomoxetine treatment, they had the same activation that had occurred in control children in the dlPFC, and there was no longer a decrease in oxy-HB in the vlPFC (Araki, et al., 2014).

Stop-Signal Task (SST)

In the SST (Logan, et al., 1984), participants are trained to execute an action, such as pressing a button, in response to a visually presented stimulus. However, on some trials, participants are signaled to withhold this response by an auditory or visual signal that occurs unpredictably. The main RRI outcome measure of the task, the SSRT, is an estimate of the amount of time a participant takes to halt the ongoing action (Logan & Cowan, 1984). Similar to the GNG, the SST is widely used and translational between clinical and preclinical models.

The SST has a high level of content validity, because the task measures willingness/ability to withhold a response (Moeller, et al., 2001). The SST has moderately high reliability, with test-retest reliability coefficients that range from r=0.61 when the first and second assessments were approximately 28 days apart (Wostmann, et al., 2013) to r=0.65 when the mean time between assessments was 8.6 days (Weafer, et al., 2013). In addition, the SST has strong concurrent validity, as performance on the SST correlates with that on the GNG, and strong discriminant validity, as it does not correlate with measures of choice impulsivity or risk-taking (Reynolds, et al., 2006). Taken together, the SST’s reliability and content, discriminant, and concurrent validity provide support for strong construct validity.

SST performance is sensitive to pharmacological and contextual manipulations such as smoking abstinence and sleep deprivation (Ashare & Hawk, 2012; Sagaspe, et al., 2007). While the SST and GNG both measure RRI, the SST is differentiated from the GNG by a long history of basic parametric manipulations (Alderson, et al., 2007; Huizenga, et al., 2009). Variations of the SST are well validated in children (Deveney, et al., 2012; Nederkoorn, et al., 2012), and the neural substrates of SST processes have been characterized in fMRI studies (Bednarski, et al., 2012; Spunt, et al., 2012).

The SST is limited by possible strategic compensations participants may adopt (e.g., delaying the Go response), and this can impact the RT distribution in unintended ways and produce unwanted noise or bias in the calculation of the SSRT. This necessitates careful training of experimenters and participants, as well as screening of data prior to analysis.

In a meta-analysis of psychiatric research using the SST, the effect sizes for higher response impulsivity on the SST were 0.62 in ADHD, 0.69 in schizophrenia, 0.39 in addiction (Lipszyc & Schachar, 2010). Taking these results together with the results of the GNG and CPT meta-analysis by the same group (Lipszyc & Schachar, 2010; Wright, et al., 2014), the authors concluded that ADHD is characterized by a more pervasive deficit in response inhibition, with high levels of both SOA and RAI. By contrast, schizophrenia was characterized by a greater deficit in SOA than RAI, and bipolar disorder was characterized by a deficit in RAI only (Wright, et al., 2014).

While several studies support the conclusion that individuals with bipolar disorder do not have a deficit in SOA when compared with healthy control subjects (Deveney, et al., 2012; Pavuluri, et al., 2012; Strakowski, et al., 2008; Weathers, et al., 2012), there were differences in neural activation during SST performance in each of these studies. For example, adults and children with bipolar disorder were characterized by less activation than healthy control participants in the right nucleus accumbens and left ventral prefrontal cortex during successful inhibition (Weathers, et al., 2012). In another study, children with bipolar disorder had less activation than healthy controls in the right nucleus accumbens during inhibition failures (Deveney, et al., 2012). When comparing neural activation in adults and children with bipolar disorder, there was an interaction during inhibition failures in the anterior cingulate cortex with children having less activation and adults having greater activation compared with age-matched healthy controls (Weathers, et al., 2012). Therefore, even in the absence of behavioral deficits, differences in the neural activation underlying SST performance may be valuable for understanding bipolar disorder.

Anti-Saccade

The anti-saccade task measures eye movements while participants follow instructions to look away from a target. Reaction time and anti-saccade errors (i.e., failure to look away from the target or resist distracter interference) are the primary outcome measures, with anti-saccade errors indexing RRI. The task has translational value given its use in humans and non-human primates (Valero-Cabre, et al., 2012), and has little error variance. The anti-saccade task does not elicit an anxiety response and is less susceptible to motivation effects than the conventional GNG. The task has established sensitivity to manipulations including methylphenidate and nicotine consumption (Dawkins, et al., 2009) and can be employed throughout the lifespan.

The anti-saccade task has strong concurrent validity (Spinella, 2004) but relatively poor discriminant validity, with task scores correlating with self-report measures of related constructs (e.g., Boredom Susceptibility on the Sensation Seeking Scale) (Pettiford, et al., 2007) and symptom severity in psychiatric conditions including autism (Mosconi, et al., 2009) and schizophrenia (Turetsky, et al., 2007). Test-retest reliability when assessed in a sample of children, adolescents, and young adults with a mean of 18.9 months between assessments was moderate, with a coefficient of r=0.48 (Klein & Fischer, 2005). When considered together, the poor discriminant validity and moderate test-retest reliability of the anti-saccade indicate that the task has limited construct validity.

Neural regions subserving antisaccade performance are more regionally localized than those involved in GNG or SST performance, which can be considered both an attribute and a limitation of the task with regard to basic processes and work with special populations. In addition to its reduced construct validity, the anti-saccade is limited by high cost of the required apparatus, lack of standardization, and susceptibility to individual differences in vision.

In addition, it should be noted that the antisaccade task involves eye movements rather than hand movements, eliciting patterns of neural activation in regions that are specific to the task. In neuroimaging research, the frontal eye field and the supplementary eye field interacted with the ventrolateral PFC during response inhibition on the antisaccade task (Heinen, et al., 2006), and a lesion study with frontal lobe patients provided support for these findings (Hodgson, et al., 2007). Because the areas of activation elicited by the antisaccade task do not overlap with other response inhibition tasks, caution is warranted when comparing results across tasks.

Of all psychiatric disorders, anti-saccades have been most widely studied among people with schizophrenia, who have higher levels of anticipatory anti-saccade errors than do healthy control subjects (Hutton & Ettinger, 2006; Turetsky, et al., 2007). Compared to the large body of anti-saccade research in schizophrenia, there are relatively few studies in which anti-saccade performance is examined in other disorders. Some research has reported higher levels of anti-saccade errors in individuals with bipolar disorder compared with healthy control participants (Gooding & Tallent, 2001; Katsanis, et al., 1997). However, research also has indicated that performance is not temporally stable in individuals with bipolar disorder, suggesting that anti-saccade deficits may be a state, rather than a trait, marker of bipolar disorder (Gooding, et al., 2004; Hutton & Ettinger, 2006).

Other tasks

Other domains may be associated with impulsivity or aspects thereof. Tasks assessing such domains include risk-taking on the Balloon Analogue Risk task (BART); cognitive control on the Simon, Flanker and Stroop tasks; decision-making on the Iowa Gambling task; and perseveration on the Intradimensional/Extradimensional Set Shifting task. These tasks may involve assessments of reaction times that might link to or correlate with measures of RRI. However, these tasks were designed to measure processes other than RRI and should not be interpreted as assessing RRI.

Practical Considerations

Characteristics and capabilities of research populations in which RRI measures are employed can differ greatly from the population in which the RRI measures were developed, and cognitive capacity and levels of RRI can vary significantly across different age groups and research populations (Butler & Zacks, 2006; Luna, et al., 2010; Williams, et al., 1999), raising questions about interpretability of RRI task performance. Therefore, careful consideration of the characteristics of the study population and the features of a particular RRI measure is warranted. Using a RRI measure in a new population requires consideration and/or evaluation of the performance range of RRI scores and consideration of other relevant performance variables (e.g., attention span, motivation) that may influence the interpretability of a given performance.

Distributional Issues

Relative to other types of behavioral impulsivity measures (e.g., choice), RRI measures are fairly sensitive to bias relating to a mismatch between task difficulty and participant capability, which can result in non-normal (skewed) distributions of scores that may lead to floor/ceiling effects. This effect can be observed in studies that report a very low mean impulsivity score (near zero) or large variance in scores. Typically, such studies fail to find group or treatment differences except in cases in which the standard deviation of scores exceeds that of the mean. Difficulties introduced by floor effects and positively skewed data include: 1) compromise in the robustness of parametric tests occurring with unequal variance and sample size, as well as outliers; 2) non-normality in the residuals of general linear model tests; and 3) problems with unequal sample size, unequal variance between groups, and leverage (Sawilowsky & Blair, 1992; Stonehouse & Forrester, 1998). As a result, both type I and type II errors, decreased power, and threats to assumptions of parametric tests are introduced when task parameters unsuitable to the population produce aberrant data distributions.

Determining whether a task has been used previously in comparable populations is important when selecting RRI tasks. If it has been used previously, researchers should determine the performance range of RRI scores and whether the central tendency nears a floor-level effect. Specifically, whether the scoring range allows for the detection of divergence between groups and/or improvement or worsening of performance in response to treatment should be determined. If researchers plan an intervention requiring repeated-measures testing, determination of whether the test in question provides acceptable test-retest reliability is important.

Avoiding problems with performance range may be achieved by selecting RRI procedures that allow for adjustment of task parameters to match participants’ capabilities. Some procedures offer manual manipulation of task parameters (e.g., interstimulus presentation interval, onset of stop signal), although such changes may require pilot testing. An alternative approach is to use a trial-by-trial adjustment procedure to titrate the task difficulty to individuals’ level of performance. This approach enables the same basic task to be used with a range of populations varying in their inhibitory capacity. It should be noted, however, that the adjustment procedure requires careful screening of individual participants for convergence. Further, adjusting task parameters to participants’ capabilities may limit comparability of scores across and within experiments, introducing measurement complexity and reducing generalizability. In summary, thoughtful selection of RRI tasks or task parameters can minimize the threat of obtaining non-normal, skewed distributions in RRI performance.

With respect to pre-clinical studies, similar considerations should be taken into account, particularly with respect to animal models of human conditions. Through careful consideration of the clinical characteristics of individuals with the disorders being modeled and the manipulations employed to mimic the conditions, one might select appropriate tasks and employ relevant modifications. Such efforts should aim towards harmonizing assessments across human and non-human investigations in order to facilitate comparisons and integration of findings.

Evaluating Interpretability

RRI measures usually record additional data that are useful to evaluate the interpretability of test performance, such as latency to initiate a response and an overall measure of discriminability and accuracy, such as the signal detection parameter d’ (Gescheider, 1985). Prior to analyses of impulsive performance, there should be an evaluation of interpretability of performance. This should involve inspection of other response variables, beyond RRI scores, to determine whether they fall within a range of performance that reflects effortful performance. This requires establishing exclusion criteria for outlier performance. There are several approaches to establishing these criteria: 1) excluding based on below-chance target responses; 2) excluding based on cut-off thresholds reported in previous reports; or 3) developing local norms that are specific to the target population, which typically requires a large number of cases to allow for the evaluation of the distribution of performance and identification of outliers. Examination of response data should take place prior to data analysis, and exclusion criteria and rates should be reported in the publication of these findings.

Summary and Discussion

RRI has been implicated in major public health problems including personality disorders, substance and non-substance addictions, impulsive aggression, attention deficit hyperactivity disorder and suicide. The multiple models of RRI and tools for its assessment may lead to conceptual confusion and difficulties in making comparisons across studies. A consilience of RRI concepts and methods would enhance understanding of the construct, improve collaboration among RRI researchers from diverse disciplines, and move the field forward. Tasks measuring two conceptually and neurobiologically distinct types of RRI, RAI (e.g., GNG, CPT, 5-CSRTT) and SOA (e.g., SST), may capture distinct aspects of the construct, each of which is encompassed by the biopsychosocial definition of RRI (Moeller, et al., 2001), and may relate to distinct clinical outcomes. Important differences between SOA and RAI warrant consideration in the selection of the most appropriate assessment for addressing specific research questions. The InSRI group recommends that researchers use both types of tasks (RAI, SOA) in each RRI study. Use of both types of measures in the same study will allow for direct comparisons between the two types of RRI, and will allow associations among each type of RRI with various outcome measures to be examined. In clinical research, this might be achieved by using SST with CPT or GNG tasks to assess RRI. In preclinical research, training considerations may limit the feasibility of administering more than one task to the same animal subject, although this has been accomplished by some groups (Broos, et al., 2012). Generally, preclinical researchers can include both types of tasks by conducting multiple-group experiments with subjects from the same species that each use one of the types of tasks to assess RRI. Additionally, preclinical research should be mindful of the conditions being modeled in animals, take into account any task modifications that might relate importantly to the condition being modeled or biological manipulations being employed, and aim towards harmonizing measures across human and non-human studies in manners consistent with RDoC (Insel, et al., 2010), PhenX (https://www.phenxtoolkit.org) and other initiatives.

In addition to its enhancement of research capabilities, the InSRI group concluded that the development of a clear conceptualization of the RRI construct will have important clinical implications. This is certainly the case with aspects of psychiatric conditions (e.g., bipolar disorder, addictive disorders) and also is true for PDs such as Borderline and Antisocial PD, in which aspects of impulsivity play a core role in diagnosis. The high rates of co-morbidity across these psychiatric disorders emphasize RRI as a central endophenotype in several models of psychiatric disease.

Despite clear consensus that impulsivity (broadly defined) is a key feature of several psychiatric disorders, the subtle distinctions among facets of the multidimensional construct, as detailed herein, often are not addressed. Given the current prevailing perspective that personality disorders are not immutable conditions with treatment and even may change dramatically over time without intervention, assessing change can be facilitated with a clear and measurable definition of impulsivity.

Acknowledgments

The authors would like to acknowledge the participants of the 2012 InSRI meeting for thoughtful discussions.

Support: This research was supported by the following grants and programs: the National Institutes of Health grants P20 DA027844, P50 DA09241, RL1 AA017539, R01 DA018647, the International Society for Research on Impulsivity, the Connecticut State Department of Mental Health and Addictions Services, the Connecticut Mental Health Center, and the Yale Gambling Center of Research Excellence Award grant from the National Center for Responsible Gaming. The funding agencies did not provide input or comment on the content of the manuscript, and the content of the manuscript reflects the contributions and thoughts of the authors and do not necessarily reflect the views of the funding agencies.

List of Abbreviations

RRI

Rapid Response Impulsivity

RAI

refraining from action initiation

SOA

stopping an ongoing action

GNG

Go/No Go task

SST

Stop Signal task

CSRT

Choice Serial Reaction Time Task

CPT

Continuous Performance task

PD

Personality Disorder

Footnotes

Disclosures

The authors report no financial conflicts of interest with respect to the content of this manuscript. Dr. Potenza has received financial support or compensation for the following: Dr. Potenza has consulted for and advised Boehringer Ingelheim, Lundbeck, Ironwood, Shire and INSYS; has consulted for and has financial interests in Somaxon; has received research support from the National Institutes of Health, Veteran’s Administration, Mohegan Sun Casino, the National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, and Forest Laboratories, Ortho-McNeil, Oy-Control/Biotie, Glaxo-SmithKline, and Psyadon pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for gambling entities, law offices and the federal public defender’s office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr. Moeller has consulted for Boehringer Ingelheim. Dr. Wing has received investigator-initiated grant funding from Pfizer. Dr. Winstanley has sat on an Advisory Board for Shire and received due compensation. Dr. Hamilton has received training and research support from the National Institutes of Health. Dr. Clark has consulted for Cambridge Cognition, Ltd.

References

  1. Alderson RM, Rapport MD, Kofler MJ. Attention-deficit/hyperactivity disorder and behavioral inhibition: A meta-analytic review of the stop-signal paradigm. J Abnorm Child Psychol. 2007;35:745–758. doi: 10.1007/s10802-007-9131-6. [DOI] [PubMed] [Google Scholar]
  2. Anastasio N, Stoffel E, Fox R, Bubar M, Rice K, Moeller F, et al. Serotonin (5-hydroxytryptamine) 5-HT2A receptor: Association with inherent and cocaine-evoked behavioral disinhibition in rats. Behav Pharmacol. 2011;22:248–261. doi: 10.1097/FBP.0b013e328345f90d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anastasio NC, Gilbertson SR, Bubar MJ, Agarkov A, Stutz SJ, Jeng Y, Bremer NM, Smith TD, Fox RG, Swinford SE, Seitz PK, Charendoff MN, Craft JW, Laezza FM, Watson CS, Briggs JM, Cunningham KA. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior. J Neurosci. 2013;33:1615–1630. doi: 10.1523/JNEUROSCI.2656-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Araki A, Ikegami M, Okayama A, Matsumoto N, Takahashi S, Azuma H, Takahashi M. Improved prefrontal activity in AD/HD children treated with atomoxetine: A NIRS study. Brain Dev. 2014 doi: 10.1016/j.braindev.2014.03.011. [DOI] [PubMed] [Google Scholar]
  5. Aron R, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci. 2003;6:115–116. doi: 10.1038/nn1003. [DOI] [PubMed] [Google Scholar]
  6. Ashare RL, Hawk LW. Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms. Psychopharmacology (Berl) 2012;219:537–547. doi: 10.1007/s00213-011-2324-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Avila C. Distinguishing BIS-mediated and BAS-mediated disinhibition mechanisms: A comparison of disinhibition models of Gray (1981, 1987) and of Patterson and Newman (1993) J Pers Soc Psychol. 2001;80:311–324. doi: 10.1037/0022-3514.80.2.311. [DOI] [PubMed] [Google Scholar]
  8. Bari A, Mar AC, Theobald DE, Elands SA, Oganya KC, Eagle DM, Robbins TW. Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci. 2011;31:9254–63. doi: 10.1523/JNEUROSCI.1543-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bari A, Robbins TW. Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol. 2013;108:44–79. doi: 10.1016/j.pneurobio.2013.06.005. [DOI] [PubMed] [Google Scholar]
  10. Bartes-Serrallonga M, Adan A, Sole-Casals J, Caldu X, Falcon C, Perez-Pamies M, Bargallo N, Serra-Grabulosa JM. Cerebral networks of sustained attention and working memory: a functional magnetic resonance imaging study based on the Continuous Performance Test. Rev Neurol. 2014;58:289–95. [PubMed] [Google Scholar]
  11. Bednarski SR, Erdman E, Luo X, Zhang S, Hu S, Li CR. Neural processes of an indirect analog of risk taking in young nondependent adult alcohol drinkers—an fMRI study of the stop signal task. Alcohol Clin Exp Res. 2012;36:768–779. doi: 10.1111/j.1530-0277.2011.01672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Berkman ET, Falk EB, Lieberman MD. In the trenches of real-world self-control: neural correlates of breaking the link between craving and smoking. Psychol Sci. 2011;22:498–506. doi: 10.1177/0956797611400918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bodnar LE, Prahme MC, Cutting LE, Denckla MB, Mahone EM. Construct validity of parent ratings of inhibitory control. Child Neuropsychol. 2007;13:345–62. doi: 10.1080/09297040600899867. [DOI] [PubMed] [Google Scholar]
  14. Boehler CN, Appelbaum LG, Krebs RM, Hopf JM, Woldorff MG. Pinning down response inhibition in the brain--conjunction analyses of the Stop-signal task. Neuroimage. 2010;52:1621–32. doi: 10.1016/j.neuroimage.2010.04.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Broos N, Diergaarde L, Schoffelmeer A, Pattij T, De Vries T. Trait impulsive choice predicts resistance to extinction and propensity to relapse to cocaine seeking: A bidirectional investigation. Neuropsychopharmacology. 2012;37:1377–1386. doi: 10.1038/npp.2011.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bubnik MG, Hawk LW, Jr, Pelham WE, Jr, Waxmonsky JG, Rosch KS. Reinforcement Enhances Vigilance Among Children With ADHD: Comparisons to Typically Developing Children and to the Effects of Methylphenidate. J Abnorm Child Psychol. 2014 doi: 10.1007/s10802-014-9891-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Buchsbaum BR, Greer S, Chang WL, Berman KF. Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes. Hum Brain Mapp. 2005;25:35–45. doi: 10.1002/hbm.20128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Butler KM, Zacks RT. Age deficits in the control of prepotent responses: Evidence for an inhibitory decline. Psychol Aging. 2006;21:638–643. doi: 10.1037/0882-7974.21.3.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Carli M, Robbins T, Evenden J, Everitt B. Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res. 1983;9:361–380. doi: 10.1016/0166-4328(83)90138-9. [DOI] [PubMed] [Google Scholar]
  20. Chao HH, Luo X, Chang JL, Li CS. Activation of the pre-supplementary motor area but not inferior prefrontal cortex in association with short stop signal reaction time--an intra-subject analysis. BMC Neurosci. 2009;10:75. doi: 10.1186/1471-2202-10-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cole B, Robbins T. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res. 1989;33:165–179. doi: 10.1016/s0166-4328(89)80048-8. [DOI] [PubMed] [Google Scholar]
  22. Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med. 2006;119:166, e7–16. doi: 10.1016/j.amjmed.2005.10.036. [DOI] [PubMed] [Google Scholar]
  23. Craig AD. Emotional moments across time: a possible neural basis for time perception in the anterior insula. Philos Trans R Soc Lond B Biol Sci. 2009;364:1933–42. doi: 10.1098/rstb.2009.0008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Crockett MJ, Clark L, Robbins TW. Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci. 2009;29:11993–11999. doi: 10.1523/JNEUROSCI.2513-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cunningham K, Anastasio N, Fox R, Stutz S, Bubar M, Swinford S, Watson C, Gilbertson S, Rice K, Rosenzweig-Lipson S, Moeller F. Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci. 2013;16:110–21. doi: 10.1021/cn300072u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cyders MA, Coskunpinar A. Measurement of constructs using self-report and behavioral lab tasks: Is there overlap in nomothetic span and construct representation for impulsivity? Clin Psychol Rev. 2011;31:965–982. doi: 10.1016/j.cpr.2011.06.001. [DOI] [PubMed] [Google Scholar]
  27. Dalley JW, Fryer TD, Brichard L, Robinson SJR, Theobald DEH, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron J, Everitt BJ, Robbins TW. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315:1267–1270. doi: 10.1126/science.1137073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology. 2002;26:716–728. doi: 10.1016/S0893-133X(01)00412-2. [DOI] [PubMed] [Google Scholar]
  29. Dawkins L, Powell JH, Pickering A, Powell J, West R. Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction. 2009;104:850–858. doi: 10.1111/j.1360-0443.2009.02522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. de Wit H. Impulsivity as a determinant and consequence of drug use: A review of underlying processes. Addict Biol. 2009;1:22–31. doi: 10.1111/j.1369-1600.2008.00129.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Deveney CM, Connolly ME, Jenkins SE, Kim P, Fromm SJ, Brotman MA, Pine DS, Leibenluft E. Striatal dysfunction during failed motor inhibition in children at risk for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38:127–133. doi: 10.1016/j.pnpbp.2012.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Di Pierro R, Sarno I, Perego S, Gallucci M, Madeddu F. Adolescent nonsuicidal self-injury: the effects of personality traits, family relationships and maltreatment on the presence and severity of behaviours. Eur Child Adolesc Psychiatry. 2012;21:511–520. doi: 10.1007/s00787-012-0289-2. [DOI] [PubMed] [Google Scholar]
  33. Dillon G, Shelton D, McKinney A, Caniga M, Marcus J, Ferguson M, et al. Prefrontal cortex lesions and scopolamine impair attention performance of C57BL/6 mice in a novel 2-choice visual discrimination task. Behav Brain Res. 2009;204:67–76. doi: 10.1016/j.bbr.2009.04.036. [DOI] [PubMed] [Google Scholar]
  34. Dougherty D, Bjork J, Harper R, Marsh D, Moeller F, Mathias C, Swann A. Behavioral impulsivity paradigms: a comparison in hospitalized adolescents with disruptive behavior disorders. J Child Psychol Psychiatry. 2003;44:1145–57. doi: 10.1111/1469-7610.00197. [DOI] [PubMed] [Google Scholar]
  35. Duann JR, Ide JS, Luo X, Li CS. Functional connectivity delineates distinct roles of the inferior frontal cortex and presupplementary motor area in stop signal inhibition. J Neurosci. 2009;29:10171–9. doi: 10.1523/JNEUROSCI.1300-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Eagle D, Bari A, Robbins T. The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) 2008;199:439–456. doi: 10.1007/s00213-008-1127-6. [DOI] [PubMed] [Google Scholar]
  37. Eagle D, Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev. 2010;34:50–72. doi: 10.1016/j.neubiorev.2009.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Eagle D, Lehmann O, Theobald D, Pena Y, Zakaria R, Ghosh R, et al. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: Implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology. 2009;34:1311–1321. doi: 10.1038/npp.2008.202. [DOI] [PubMed] [Google Scholar]
  39. Fillmore MT, Weafer J. Behavioral inhibition and addiction. In: MacKillop H, de Wit H, editors. The Wiley-Blackwell Handbook of Addiction Psychopharmacology. West Sussex, UK: John Wiley and Sons Limited; 2013. pp. 135–164. [Google Scholar]
  40. Fineberg N, Chamberlain S, Goudriaan A, Stein D, Vandershuren L, Gillan C, Shekar S, Gorwood P, Voon V, Morein-Zamir S, Denys D, Sahakian B, Moeller F, Robbins T, Potenza M. New developments in human neurocognition: Clinical, genetic and brain imaging correlates of impulsivity and compulsivity. CNS Spectrums. 2014;19:68–89. doi: 10.1017/S1092852913000801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Fray PJ, Robbins TW, Sahakian BJ. Neuropsychiatric applications of CANTAB. Int J Geriatr Psychiatry. 1996;11:329–336. [Google Scholar]
  42. Gescheider GA. Psychophysics: Method, theory, and application. Hillsdale, NJ: Lawrence Erlbaum and Associates; 1985. [Google Scholar]
  43. Gooding DC, Mohapatra L, Shea HB. Temporal stability of saccadic task performance in schizophrenia and bipolar patients. Psychol Med. 2004;34:921–32. doi: 10.1017/s003329170300165x. [DOI] [PubMed] [Google Scholar]
  44. Gooding DC, Tallent KA. The association between antisaccade task and working memory task performance in schizophrenia and bipolar disorder. J Nerv Ment Dis. 2001;189:8–16. doi: 10.1097/00005053-200101000-00003. [DOI] [PubMed] [Google Scholar]
  45. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) 2010;212:603–12. doi: 10.1007/s00213-010-1994-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Gullo MJ, Loxton NJ, Dawe S. Impulsivity: Four ways five factors are not basic to addiction. Addict Behav. 2014;39:1547–56. doi: 10.1016/j.addbeh.2014.01.002. [DOI] [PubMed] [Google Scholar]
  47. Hamilton KR, Potenza MN, Grunberg NE. Lewis rats have greater response impulsivity than Fischer rats. Addict Behav. 2014;39:1565–72. doi: 10.1016/j.addbeh.2014.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hamilton KR, Sinha R, Potenza MN. Hazardous drinking and dimensions of impulsivity, behavioral approach, and inhibition in adult men and women. Alcohol Clin Exp Res. 2012;36:958–66. doi: 10.1111/j.1530-0277.2011.01708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Harmell AL, Mausbach BT, Moore RC, Depp CA, Jeste DV, Palmer BW. Longitudinal study of sustained attention in outpatients with bipolar disorder. J Int Neuropsychol Soc. 2014;20:230–7. doi: 10.1017/S1355617713001422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Harrison A, Everitt B, Robbins T. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res. 1999;100:99–112. doi: 10.1016/s0166-4328(98)00117-x. [DOI] [PubMed] [Google Scholar]
  51. Heinen SJ, Rowland J, Lee BT, Wade AR. An oculomotor decision process revealed by functional magnetic resonance imaging. J Neurosci. 2006;26:13515–22. doi: 10.1523/JNEUROSCI.4243-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hodgson T, Chamberlain M, Parris B, James M, Gutowski N, Husain M, Kennard C. The role of the ventrolateral frontal cortex in inhibitory oculomotor control. Brain. 2007;130:1525–37. doi: 10.1093/brain/awm064. [DOI] [PubMed] [Google Scholar]
  53. Hogg J, Evans P. Stimulus generalization following extra-dimensional training in educationally subnormal (severely) children. Br J Psychol. 1975;66:211–224. doi: 10.1111/j.2044-8295.1975.tb01457.x. [DOI] [PubMed] [Google Scholar]
  54. Huizenga HM, van Bers BMCW, Plat J, van den Wildenberg WPM, van der Molen MW. Task complexity enhances response inhibition deficits in childhood and adolescent attention-deficit/hyperactivity disorder: A meta-regression analysis. Biol Psychiatry. 2009;65:39–45. doi: 10.1016/j.biopsych.2008.06.021. [DOI] [PubMed] [Google Scholar]
  55. Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43:302–13. doi: 10.1111/j.1469-8986.2006.00403.x. [DOI] [PubMed] [Google Scholar]
  56. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51. doi: 10.1176/appi.ajp.2010.09091379. [DOI] [PubMed] [Google Scholar]
  57. Isoda M, Hikosaka O. Switching from automatic to controlled action by monkey medial frontal cortex. Nat Neurosci. 2007;10:240–8. doi: 10.1038/nn1830. [DOI] [PubMed] [Google Scholar]
  58. Iversen S, Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res. 1970;11:376–386. doi: 10.1007/BF00237911. [DOI] [PubMed] [Google Scholar]
  59. Jakubowska E, Gray J. Effects of septal lesion on go, no-go differentiation and reversal learning in rats. Acta Neurobiol Exp (Wars) 1982;42:327–341. [PubMed] [Google Scholar]
  60. Kaiser S, Unger J, Kiefer M, Markela J, Mundt C, Weisbrod M. Executive control deficit in depression: event-related potentials in a Go/Nogo task. Psychiatry Res. 2003;122:169–84. doi: 10.1016/s0925-4927(03)00004-0. [DOI] [PubMed] [Google Scholar]
  61. Katsanis J, Kortenkamp S, Iacono WG, Grove WM. Antisaccade performance in patients with schizophrenia and affective disorder. J Abnorm Psychol. 1997;106:468–72. doi: 10.1037//0021-843x.106.3.468. [DOI] [PubMed] [Google Scholar]
  62. Katz R, De Sanctis P, Mahoney JR, Sehatpour P, Murphy CF, Gomez-Ramirez M, Alexopoulos GS, Foxe JJ. Cognitive control in late-life depression: response inhibition deficits and dysfunction of the anterior cingulate cortex. Am J Geriatr Psychiatry. 2010;18:1017–25. doi: 10.1097/JGP.0b013e3181d695f2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Klein C, Fischer B. Instrumental and test-retest reliability of saccadic measures. Biol Psychol. 2005;68:201–13. doi: 10.1016/j.biopsycho.2004.06.005. [DOI] [PubMed] [Google Scholar]
  64. Lane SD, Cherek DR, Rhoades HM, Pietras CJ, Tcheremissine OV. Relationships among laboratory and psychometric measures of impulsivity: Implications in substance abuse and dependence. Addict Disord Their Treat. 2003;2:33–40. [Google Scholar]
  65. Langenecker SA, Kennedy SE, Guidotti LM, Briceno EM, Own LS, Hooven T, Young EA, Akil H, Noll DC, Zubieta JK. Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol Psychiatry. 2007;62:1272–80. doi: 10.1016/j.biopsych.2007.02.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction. 2009;104:1006–15. doi: 10.1111/j.1360-0443.2009.02533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Lejuez CW, Magidson JF, Mitchell SH, Sinha R, Stevens MC, de Wit H. Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res. 2010;34:1334–1345. doi: 10.1111/j.1530-0277.2010.01217.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Lenartowicz A, Kalar DJ, Congdon E, Poldrack RA. Towards an ontology of cognitive control. Top Cogn Sci. 2010;2:678–92. doi: 10.1111/j.1756-8765.2010.01100.x. [DOI] [PubMed] [Google Scholar]
  69. Lipszyc J, Schachar R. Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J Int Neuropsychol Soc. 2010;16:1064–76. doi: 10.1017/S1355617710000895. [DOI] [PubMed] [Google Scholar]
  70. Littlefield A, Sher K, Steinley D. Developmental trajectories of impulsivity and their association with alcohol use and related outcomes during emerging and young adulthood. Alcohol Clin Exp Res. 2010;34:1409–16. doi: 10.1111/j.1530-0277.2010.01224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Logan G, Cowan W. On the ability to inhibit thought and action-a theory of an act of control. Psychol Rev. 1984;91 doi: 10.1037/a0035230. [DOI] [PubMed] [Google Scholar]
  72. Logan G, Cowan W, Davis K. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984;10:276–291. doi: 10.1037//0096-1523.10.2.276. [DOI] [PubMed] [Google Scholar]
  73. Luna B, Padmanabhan A, O’Hearn K. What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn. 2010;72:101–113. doi: 10.1016/j.bandc.2009.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Meda S, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM, Thomas AD, Muska C, Hylton JL, Pearlson GD. Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol. 2009;20:390–399. doi: 10.1097/FBP.0b013e32833113a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Medford N, Critchley HD. Conjoint activity of anterior insular and anterior cingulate cortex: awareness and response. Brain Struct Funct. 2010;214:535–49. doi: 10.1007/s00429-010-0265-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Menon V, Adleman NE, White CD, Glover GH, Reiss AL. Error-related brain activation during a Go/NoGo response inhibition task. Hum Brain Mapp. 2001;12:131–43. doi: 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214:655–67. doi: 10.1007/s00429-010-0262-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158:1783–1793. doi: 10.1176/appi.ajp.158.11.1783. [DOI] [PubMed] [Google Scholar]
  79. Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, Valdes I, Swann AC, Barratt ES, Narayana PA. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology. 2005;30:610–617. doi: 10.1038/sj.npp.1300617. [DOI] [PubMed] [Google Scholar]
  80. Mosconi M, Cody-Hazlett H, Poe M, Gerig G, Gimpel-Smith R, Piven J. Longitudinal study of amygdala volume and joint attention in 2- to 4-year-old children with autism. Arch Gen Psychiatry. 2009;66 doi: 10.1001/archgenpsychiatry.2009.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Mostofsky SH, Schafer JG, Abrams MT, Goldberg MC, Flower AA, Boyce A, Courtney SM, Calhoun VD, Kraut MA, Denckla MB, Pekar JJ. fMRI evidence that the neural basis of response inhibition is task-dependent. Brain Res Cogn Brain Res. 2003;17:419–30. doi: 10.1016/s0926-6410(03)00144-7. [DOI] [PubMed] [Google Scholar]
  82. Mostofsky SH, Simmonds DJ. Response inhibition and response selection: two sides of the same coin. J Cogn Neurosci. 2008;20:751–61. doi: 10.1162/jocn.2008.20500. [DOI] [PubMed] [Google Scholar]
  83. Mouilso ER, Calhoun KS, Rosenbloom TG. Impulsivity and sexual assault in college men. Violence and Victims. 2013;28:429–442. doi: 10.1891/0886-6708.vv-d-12-00025. [DOI] [PubMed] [Google Scholar]
  84. Muir JL, Everitt BJ, Robbins TW. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral and parietal cortex on a five choice serial reaction time task. Cerebral Cortex. 1996;6:470–81. doi: 10.1093/cercor/6.3.470. [DOI] [PubMed] [Google Scholar]
  85. Murphy FC, Sahakian B, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES. Emotional bias and inhibitory control processes in mania and depression. Psychol Med. 1999;29:1307–1321. doi: 10.1017/s0033291799001233. [DOI] [PubMed] [Google Scholar]
  86. Nederkoorn C, Coelho JS, Guerrieri R, Houben K, Jansen A. Specificity of the failure to inhibit responses in overweight children. Appetite. 2012;59:409–413. doi: 10.1016/j.appet.2012.05.028. [DOI] [PubMed] [Google Scholar]
  87. Nelson SM, Dosenbach NU, Cohen AL, Wheeler ME, Schlaggar BL, Petersen SE. Role of the anterior insula in task-level control and focal attention. Brain Struct Funct. 2010;214:669–80. doi: 10.1007/s00429-010-0260-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Newman JP, Wallace JF, Schmitt WA, Arnett PA. Behavioral inhibition system functioning in anxious, impulsive, and psychopathic individuals. Pers Indiv Differ. 1997;23:583–592. [Google Scholar]
  89. Nixon NL, Liddle PF, Worwood G, Liotti M, Nixon E. Prefrontal cortex function in remitted major depressive disorder. Psychol Med. 2013;43:1219–30. doi: 10.1017/S0033291712002164. [DOI] [PubMed] [Google Scholar]
  90. Ogg RJ, Zou P, Allen DN, Hutchins SB, Dutkiewicza RM, Mulhern RK. Neural correlates of a clinical continuous performance test. Magn Reson Imaging. 2008;26:504–512. doi: 10.1016/j.mri.2007.09.004. [DOI] [PubMed] [Google Scholar]
  91. Page LA, Rubia K, Deeley Q, Daly E, Toal F, Mataix-Cols D, Giampietro V, Schmitz N, Murphy DG. A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res. 2009;174:202–9. doi: 10.1016/j.pscychresns.2009.05.002. [DOI] [PubMed] [Google Scholar]
  92. Paine TA, Slipp LE, Carlezon WA., Jr Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors. Neuropsychopharmacology. 2011;36:1703–13. doi: 10.1038/npp.2011.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Pan LA, Batezati-Alves SC, Almeida JR, Segreti A, Akkal D, Hassel S, Lakdawala S, Brent DA, Phillips ML. Dissociable patterns of neural activity during response inhibition in depressed adolescents with and without suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2011;50:602–611. e3. doi: 10.1016/j.jaac.2011.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Pattij T, Vanderschuren LJMJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci. 2008;29:192–199. doi: 10.1016/j.tips.2008.01.002. [DOI] [PubMed] [Google Scholar]
  95. Pavuluri MN, Ellis JA, Wegbreit E, Passarotti AM, Stevens MC. Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania. Behav Brain Res. 2012;226:493–503. doi: 10.1016/j.bbr.2011.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 2008;200:1–26. doi: 10.1007/s00213-008-1173-0. [DOI] [PubMed] [Google Scholar]
  97. Pettiford J, Kozink R, Lutz A, Kollins S, Rose J, McClernon F. Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility. Addict Behav. 2007;32:2351–2357. doi: 10.1016/j.addbeh.2007.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Picton TW, Stuss DT, Alexander MP, Shallice T, Binns MA, Gillingham S. Effects of focal frontal lesions on response inhibition. Cereb Cortex. 2007;17:826–38. doi: 10.1093/cercor/bhk031. [DOI] [PubMed] [Google Scholar]
  99. Posada C, Moore DJ, Deutsch R, Rooney A, Gouaux B, Letendre S, Grant I, Atkinson JH. Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder. J Neuropsychiatry Clin Neurosci. 2012;24:61–70. doi: 10.1176/appi.neuropsych.11010028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Prisciandaro JJ, Myrick H, Henderson S, McRae-Clark AL, Brady KT. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend. 2013;131:44–9. doi: 10.1016/j.drugalcdep.2013.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol. 2006;17:651–667. doi: 10.1097/FBP.0b013e3280115f99. [DOI] [PubMed] [Google Scholar]
  102. Reynolds B, Ortengren A, Richards JB, de Wit H. Dimensions of impulsive behavior: Personality and behavioral measures. Pers Indiv Differ. 2006;40:305–315. [Google Scholar]
  103. Robbins T. The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry. Psychopharmacology. 2002;163:362–380. doi: 10.1007/s00213-002-1154-7. [DOI] [PubMed] [Google Scholar]
  104. Robinson E, Eagle D, Economidou D, Theobald D, Mar A, Murphy E, et al. Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in ‘waiting’ versus ‘stopping’. Behav Brain Res. 2009;196:310–316. doi: 10.1016/j.bbr.2008.09.021. [DOI] [PubMed] [Google Scholar]
  105. Roth RM, Saykin AJ, Flashman LA, Pixley HS, West JD, Mamourian AC. Event-related functional magnetic resonance imaging of response inhibition in obsessive-compulsive disorder. Biol Psychiatry. 2007;62:901–9. doi: 10.1016/j.biopsych.2006.12.007. [DOI] [PubMed] [Google Scholar]
  106. Rubia K, Halari R, Christakou A, Taylor E. Impulsiveness as a timing disturbance: Neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philos Trans R Soc Lond B Biol Sci. 2009;364:1919–1931. doi: 10.1098/rstb.2009.0014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Rubia K, Russell T, Overmeyer S, Brammer M, Bullmore E, Sharma T, et al. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage. 2001;13:250–261. doi: 10.1006/nimg.2000.0685. [DOI] [PubMed] [Google Scholar]
  108. Sagaspe P, Philip P, Schwartz S. Inhibitory motor control in apneic and insomniac patients: A stop task study. J Sleep Res. 2007;167:381–3. doi: 10.1111/j.1365-2869.2007.00607.x. [DOI] [PubMed] [Google Scholar]
  109. Sawilowsky S, Blair RC. A more realistic look at the robustness and type II error properties of the t test to departures from population normality. Psychol Bull. 1992;111:353–360. [Google Scholar]
  110. Schachar R, Logan G, Robaey P, Chen S, Ickowicz A, Barr C. Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol. 2007;35:229–238. doi: 10.1007/s10802-006-9075-2. [DOI] [PubMed] [Google Scholar]
  111. Schepis TS, McFetridge A, Chaplin TM, Sinha R, Krishnan-Sarin S. A pilot examination of stress-related changes in impulsivity and risk taking as related to smoking status and cessation outcome in adolescents. Nicotine Tob Res. 2011;13:611–615. doi: 10.1093/ntr/ntr022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349–2356. doi: 10.1523/JNEUROSCI.5587-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Sepede G, Ferretti A, Perrucci MG, Gambi F, Di Donato F, Nuccetelli F, Del Gratta C, Tartaro A, Salerno RM, Ferro FM, Romani GL. Altered brain response without behavioral attention deficits in healthy siblings of schizophrenic patients: An event-related fMRI study. Neuroimage. 2010;49:1080–1090. doi: 10.1016/j.neuroimage.2009.07.053. [DOI] [PubMed] [Google Scholar]
  114. Simmonds DJ, Pekara JJ, Mostofskya SH. Meta-analysis of go/no-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent. Neuropsychologia. 2008;46:224–232. doi: 10.1016/j.neuropsychologia.2007.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Smith G, Fischer S, Cyders M, Annus A, Spillane N, McCarthy D. On the validity and utility of discriminating among impulsivity-like traits. Assessment. 2007;14:155–170. doi: 10.1177/1073191106295527. [DOI] [PubMed] [Google Scholar]
  116. Sofuoglu M, Herman AI, Li Y, Waters A. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a go no-go task in abstinent cigarette smokers: a preliminary report. Psychopharmacology (Berl) 2012;224:413–20. doi: 10.1007/s00213-012-2763-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Spinella M. Neurobehavioral correlates of impulsivity: Evidence of prefrontal involvement. Int J Neurosci. 2004;114:95–104. doi: 10.1080/00207450490249347. [DOI] [PubMed] [Google Scholar]
  118. Spunt RP, Lieberman MD, Cohen JR, Eisenberger NI. The phenomenology of error processing: The dorsal ACC response to stop-signal errors tracks reports of negative affect. J Cogn Neurosci. 2012;24:1753–1765. doi: 10.1162/jocn_a_00242. [DOI] [PubMed] [Google Scholar]
  119. Stonehouse J, Forrester G. Robustness of the t and U tests under combined assumption violations. J Appl Stat. 1998;25:63–74. [Google Scholar]
  120. Strakowski S, Fleck D, DelBello M, Adler C, Shear P, Kotwal R, Arndt S. Impulsivity across the course of bipolar disorder. Bipolar Disord. 2010;12:285–297. doi: 10.1111/j.1399-5618.2010.00806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Strakowski SM, Adler CM, Cerullo M, Eliassen JC, Lamy M, Fleck DE, Lee JH, DelBello MP. Magnetic resonance imaging brain activation in first-episode bipolar mania during a response inhibition task. Early Interv Psychiatry. 2008;2:225–33. doi: 10.1111/j.1751-7893.2008.00082.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Swann AC, Bjork JM, Moeller FG, Dougherty DM. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry. 2002;51:988–994. doi: 10.1016/s0006-3223(01)01357-9. [DOI] [PubMed] [Google Scholar]
  123. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162:1680–1687. doi: 10.1176/appi.ajp.162.9.1680. [DOI] [PubMed] [Google Scholar]
  124. Swick D, Ashley V, Turken AU. Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci. 2008;9:102. doi: 10.1186/1471-2202-9-102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Swick D, Ashley V, Turken U. Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks. Neuroimage. 2011;56:1655–1665. doi: 10.1016/j.neuroimage.2011.02.070. [DOI] [PubMed] [Google Scholar]
  126. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull. 2007;33:69–94. doi: 10.1093/schbul/sbl060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Valero-Cabre A, Wattiez N, Monfort M, François C, Rivaud-Péchoux S, Gaymard B, Pouget P. Frontal non-invasive neurostimulation modulates antisaccade preparation in non-human primates. PLOS One. 2012;7:e38674. doi: 10.1371/journal.pone.0038674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. van Gaalen M, Brueggeman R, Bronius P, Schoffelmeer A, Vanderschuren L. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 2006a;187:73–85. doi: 10.1007/s00213-006-0396-1. [DOI] [PubMed] [Google Scholar]
  129. van Gaalen M, van Koten R, Schoffelmeer A, Vanderschuren L. Critical involvement of dopamine neurotransmission in impulsive decision making. Biol Psychiatry. 2006b;60:66–73. doi: 10.1016/j.biopsych.2005.06.005. [DOI] [PubMed] [Google Scholar]
  130. Verbruggen F, Logan G. Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev. 2009;33:647–661. doi: 10.1016/j.neubiorev.2008.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Watanabe J, Sugiura M, Sato K, Sato Y, Maeda Y, Matsue Y, Fukuda H, Kawashima R. The human prefrontal and parietal association cortices are involved in NO-GO performances: an event-related fMRI study. Neuroimage. 2002;17:1207–16. doi: 10.1006/nimg.2002.1198. [DOI] [PubMed] [Google Scholar]
  132. Weafer J, Baggott MJ, de Wit H. Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Exp Clin Psychopharmacol. 2013;21:475–81. doi: 10.1037/a0033659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Weathers JD, Stringaris A, Deveney CM, Brotman MA, Zarate CA, Jr, Connolly ME, Fromm SJ, LeBourdais SB, Pine DS, Leibenluft E. A developmental study of the neural circuitry mediating motor inhibition in bipolar disorder. Am J Psychiatry. 2012;169:633–41. doi: 10.1176/appi.ajp.2012.11081244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Williams B, Ponesse J, Schachar R, Logan G, Tannock R. Development of inhibitory control across the life span. Dev Psychol. 1999;35:205–213. doi: 10.1037//0012-1649.35.1.205. [DOI] [PubMed] [Google Scholar]
  135. Winstanley C. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol. 2011;164:1301–1321. doi: 10.1111/j.1476-5381.2011.01323.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Winstanley C, Dalley J, Theobald D, Robbins T. Fractionating impulsivity: Contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology. 2004a;29:1331–1343. doi: 10.1038/sj.npp.1300434. [DOI] [PubMed] [Google Scholar]
  137. Winstanley CA, Theobald DEH, Dalley JW, Glennon JC, Robbins TW. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 2004b;176:376–385. doi: 10.1007/s00213-004-1884-9. [DOI] [PubMed] [Google Scholar]
  138. Wiskerke J, Schetters D, van Es IE, van Mourik Y, den Hollander BR, Schoffelmeer AN, Pattij T. μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. J Neurosci. 2011;31:262–272. doi: 10.1523/JNEUROSCI.4794-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Wostmann NM, Aichert DS, Costa A, Rubia K, Moller HJ, Ettinger U. Reliability and plasticity of response inhibition and interference control. Brain Cogn. 2013;81:82–94. doi: 10.1016/j.bandc.2012.09.010. [DOI] [PubMed] [Google Scholar]
  140. Wright L, Lipszyc J, Dupuis A, Thayapararajah SW, Schachar R. Response inhibition and psychopathology: a meta-analysis of go/no-go task performance. J Abnorm Psychol. 2014;123:429–39. doi: 10.1037/a0036295. [DOI] [PubMed] [Google Scholar]

RESOURCES